AI assistant
CONMED Corp — Director's Dealing 2022
Mar 8, 2022
31971_dirs_2022-03-08_eb700bba-0945-4e8b-8d28-2ff021dd3ee4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-03-04
Reporting Person: Jonas Daniel S (EVP Legal Affairs,Gen. Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-04 | Common Stock | M | 1390 | $41.93 | Acquired | 13557 | Direct |
| 2022-03-04 | Common Stock | S | 1390 | $143.296 | Disposed | 12167 | Direct |
| 2022-03-04 | Common Stock | M | 3610 | $41.93 | Acquired | 15777 | Direct |
| 2022-03-04 | Common Stock | S | 3610 | $142.4214 | Disposed | 12167 | Direct |
| 2022-03-04 | Common Stock | M | 5600 | $59.96 | Acquired | 17767 | Direct |
| 2022-03-04 | Common Stock | S | 5600 | $142.50 | Disposed | 12167 | Direct |
| 2022-03-04 | Common Stock | M | 11157 | $78.76 | Acquired | 23324 | Direct |
| 2022-03-04 | Common Stock | S | 11157 | $142.50 | Disposed | 12167 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-04 | Options To Purchase Common Stock | $41.93 | M | 1390 | Disposed | 2027-03-01 | Common Stock (1390) | Direct |
| 2022-03-04 | Options To Purchase Common Stock | $41.93 | M | 3610 | Disposed | 2027-03-01 | Common Stock (3610) | Direct |
| 2022-03-04 | Options To Purchase Common Stock | $59.96 | M | 5600 | Disposed | 2028-03-01 | Common Stock (5600) | Direct |
| 2022-03-04 | Options To Purchase Common Stock | $78.76 | M | 11157 | Disposed | 2029-03-01 | Common Stock (11157) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.28 to $143.34. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.40 to $142.54. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F4: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period